|
||||||||||
![]() |
||||||||||
|
|
|
Juvederm® | Juvederm® Ultra Plus | Juvederm® XCJuvederm® is composed of cross-linked hyaluronic acid, a natural substance found in the body. Hyaluronic acid plays a key role in the maintenance of skin volume and hydration, eye volume and shape, as well as joint lubrication and cushioning.
Hyaluronic acid retains water -- absorbing more than 1,000 times its weight -- and
adds volume to the skin’s surface. In addition, hyaluronic acid binds with collagen
and elastin, transporting essential nutrients to these fibers.
For decades, hyaluronic acid has been utilized by medical practitioners in numerous therapeutic procedures. In 2003, the U.S. Food and Drug Administration (FDA) approved the first hyaluronic acid dermal filler for the correction of facial wrinkles and folds, such as nasolabial folds (the folds running from the sides of the bottom of the nose to the outer corners of the mouth). Juvederm® comes in two formulations: Juvederm® Ultra
Juvederm® Ultra (also known as Juvederm®) is a next-generation,
cross-linked hyaluronic acid dermal filler approved by the FDA in June 2006 for
treatment of nasolabial folds. Juvederm® Ultra adds volume to the
face and smoothes
Cross-linking refers to a process in which the individual chains of hyaluronic acid are bound or ‘cross-linked’ together, transforming the liquid hyaluronic acid into a soft gel. The firmness of the gel depends on the degree of cross-linking of the individual hyaluronic acid chains. The body metabolizes cross-linked hyaluronic acid more slowly, resulting in a longer duration of effect. As an advanced, cross-linked hyaluronic acid, the results of a Juvederm® treatment will typically last up to a year or more. Results will vary depending upon injector technique, the facial area in which it is applied, and upon the individual’s muscle movement, skin and health characteristics. For example, in areas of the face where there is less exaggerated muscle movement, Juvederm® will often last longer. Regular BOTOX® treatments in conjunction with Juvederm® may help extend the duration of Juvederm®. Juvederm® is typically used to correct finer lines or for less bulking than Juvederm® Ultra Plus. Juvederm® Ultra Plus
Juvederm® Ultra Plus (also called Juvederm® Plus)
has more cross-linked molecules per ml than Juvederm®, and therefore
is used to treat deeper wrinkles and folds. Healthcare professionals also use
The most common side effects of Juvederm® Ultra and Juvederm® Ultra Plus include temporary redness, swelling, bumps and bruising. Consult your medical practitioner for complete details and potential side effects. Juvederm® XCJuvederm® XC is another option now available for the treatment of mouth area wrinkles, smile lines, vertical lip lines, marionette lines, as well as for restoring natural contours and wrinkle correction in multiple problem areas. This smooth gel filler includes lidocaine to potentially improve comfort during your treatment.
Your health care professional may use Juvederm® XC in combination with other dermal fillers and botulinum toxins to create a liquid face lift or non surgical facial rejuvenation. A medical practitioner who is more experienced with Juvederm® can often help achieve better, more pleasing and enduring results, which means you are getting more for your money. We have determined a number of medical practitioners nationally who have extensive experience or training with dermal filler medical procedures. To see a list of experienced healthcare professionals in your area, or to receive a special discount on your procedure. FOLLOW THIS LINK TO RECEIVE A SPECIAL DISCOUNT ON YOUR NEXT PROCEDURE
Featured Healthcare Professionals:
Richard Fleming, MD, Beverly Hills ~ Wm. Stephen Martin, MD, Mobile, AL J Charlie Finn, MD, Chapel Hill, NC ~ Paul M. Friedman, MD, Houston, TX Eric Desman, MD, Alexandria, VA ~ Anna M. Pare', MD, Atlanta, GA Jan Karlin, MD, Orlando, FL ~ Toby Mayer, MD, Beverly Hills Jules A. Feledy Jr. MD, Chevy Chase, MD ~ W. Grant Stevens, MD Juvederm® and BOTOX® are registered trademarks of Allergan, Inc. |
||||||||
|
||||||||||